Harmony Biosciences Holdings (HRMY) Shareholder's Equity (2019 - 2026)

Harmony Biosciences Holdings (HRMY) Shareholder's Equity (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Harmony Biosciences Holdings 1.92 Bn 1.28 Bn 170.88 Mn 910.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 910.35 Mn
Dec 31, 2025 870.22 Mn
Sep 30, 2025 835.12 Mn
Jun 30, 2025 773.08 Mn
Mar 31, 2025 720.53 Mn
Dec 31, 2024 659.16 Mn
Sep 30, 2024 596.80 Mn
Jun 30, 2024 538.58 Mn
Mar 31, 2024 515.39 Mn
Dec 31, 2023 466.99 Mn
Sep 30, 2023 481.33 Mn
Jun 30, 2023 485.17 Mn
Mar 31, 2023 443.04 Mn
Dec 31, 2022 402.84 Mn
Sep 30, 2022 343.88 Mn
Jun 30, 2022 246.53 Mn
Mar 31, 2022 214.50 Mn
Dec 31, 2021 186.51 Mn
Sep 30, 2021 152.02 Mn
Jun 30, 2021 126.55 Mn